RTW INVESTMENTS, LP
Q4 2023 13F-HR Holdings
Net value change ($000)
+1,662,290
(35.1%)
New positions
14
Sold out positions
17
Turnover %
12.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ARVN | 173,427 | NEW |
| RCKT | 167,681 | 46.3% |
| MDGL | 143,422 | 317.3% |
| RARE | 136,649 | 70.9% |
| CYTK | 134,983 | 178.0% |
| CRGX | 119,821 | NEW |
| ACAD | 111,094 | 46.0% |
| Mirati Therapeutics, Inc. | 102,814 | 34.9% |
| IMCR | 100,103 | 31.6% |
| AKRO | 83,891 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| TMO | -120,418 | -81.9% |
| ESTA | -57,814 | -47.2% |
| MLTX | -28,500 | -100.0% |
| ILMN | -25,826 | -100.0% |
| Axonics, Inc. | -24,832 | -100.0% |
| TSHA | -23,481 | -44.0% |
| SCPH | -23,481 | -100.0% |
| PMVP | -14,587 | -100.0% |
| GHRS | -14,141 | -42.3% |
| Shockwave Medical, Inc. | -12,290 | -49.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|